UniProt ID | SMAD5_HUMAN | |
---|---|---|
UniProt AC | Q99717 | |
Protein Name | Mothers against decapentaplegic homolog 5 | |
Gene Name | SMAD5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 465 | |
Subcellular Localization | Cytoplasm. Nucleus. Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with SMAD4. | |
Protein Description | Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD).. | |
Protein Sequence | MTSMASLFSFTSPAVKRLLGWKQGDEEEKWAEKAVDALVKKLKKKKGAMEELEKALSSPGQPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLDICEFPFGSKQKEVCINPYHYKRVESPVLPPVLVPRHNEFNPQHSLLVQFRNLSHNEPHMPQNATFPDSFHQPNNTPFPLSPNSPYPPSPASSTYPNSPASSGPGSPFQLPADTPPPAYMPPDDQMGQDNSQPMDTSNNMIPQIMPSISSRDVQPVAYEEPKHWCSIVYYELNNRVGEAFHASSTSVLVDGFTDPSNNKSRFCLGLLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSSIFVQSRNCNFHHGFHPTTVCKIPSSCSLKIFNNQEFAQLLAQSVNHGFEAVYELTKMCTIRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLTQMGSPLNPISSVS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTSMASLFS ------CCCHHHHHH | 27.49 | 26074081 | |
2 | Acetylation | ------MTSMASLFS ------CCCHHHHHH | 27.49 | 22223895 | |
3 | Phosphorylation | -----MTSMASLFSF -----CCCHHHHHHC | 15.85 | 26074081 | |
6 | Phosphorylation | --MTSMASLFSFTSP --CCCHHHHHHCCCH | 22.70 | 26074081 | |
9 | Phosphorylation | TSMASLFSFTSPAVK CCHHHHHHCCCHHHH | 32.67 | 29255136 | |
11 | Phosphorylation | MASLFSFTSPAVKRL HHHHHHCCCHHHHHH | 32.38 | 29255136 | |
12 | Phosphorylation | ASLFSFTSPAVKRLL HHHHHCCCHHHHHHH | 14.62 | 29255136 | |
57 | Phosphorylation | EELEKALSSPGQPSK HHHHHHHCCCCCCCC | 39.07 | 29396449 | |
58 | Phosphorylation | ELEKALSSPGQPSKC HHHHHHCCCCCCCCE | 33.62 | 21815630 | |
63 | Phosphorylation | LSSPGQPSKCVTIPR HCCCCCCCCEEECCC | 30.69 | 29396449 | |
64 | Ubiquitination | SSPGQPSKCVTIPRS CCCCCCCCEEECCCC | 39.13 | - | |
79 | Phosphorylation | LDGRLQVSHRKGLPH CCCCEEEECCCCCCE | 12.47 | 26670566 | |
82 | Ubiquitination | RLQVSHRKGLPHVIY CEEEECCCCCCEEEE | 60.42 | - | |
89 | Phosphorylation | KGLPHVIYCRVWRWP CCCCEEEEEEEEECC | 3.52 | - | |
100 | O-linked_Glycosylation | WRWPDLQSHHELKPL EECCCCCCCCCCCCC | 33.82 | 30379171 | |
128 | Phosphorylation | VCINPYHYKRVESPV EEECCCCCCCCCCCC | 8.47 | 12601080 | |
133 | Phosphorylation | YHYKRVESPVLPPVL CCCCCCCCCCCCCEE | 19.90 | 30266825 | |
152 | Phosphorylation | NEFNPQHSLLVQFRN CCCCCCHHHEEEEEC | 20.39 | 26055452 | |
188 | Phosphorylation | NNTPFPLSPNSPYPP CCCCCCCCCCCCCCC | 23.44 | - | |
306 | Ubiquitination | FTDPSNNKSRFCLGL CCCCCCCCCHHHHHH | 47.46 | - | |
315 | Phosphorylation | RFCLGLLSNVNRNST HHHHHHHCCCCCCCC | 43.72 | 21712546 | |
321 | Phosphorylation | LSNVNRNSTIENTRR HCCCCCCCCCHHHHH | 27.76 | 28348404 | |
322 | Phosphorylation | SNVNRNSTIENTRRH CCCCCCCCCHHHHHH | 35.54 | 22985185 | |
337 | Phosphorylation | IGKGVHLYYVGGEVY CCCCEEEEEECCEEE | 4.92 | 22468782 | |
338 | Phosphorylation | GKGVHLYYVGGEVYA CCCEEEEEECCEEEE | 10.05 | 22468782 | |
344 | Phosphorylation | YYVGGEVYAECLSDS EEECCEEEEHHCCCC | 7.74 | 22468782 | |
418 | Ubiquitination | TIRMSFVKGWGAEYH CEEHHHHCCCCCCHH | 47.11 | 21890473 | |
456 | Phosphorylation | KVLTQMGSPLNPISS HHHHHCCCCCCCCCC | 22.37 | 28555341 | |
462 | Phosphorylation | GSPLNPISSVS---- CCCCCCCCCCC---- | 26.41 | 22322096 | |
463 | Phosphorylation | SPLNPISSVS----- CCCCCCCCCC----- | 27.40 | 26503892 | |
465 | Phosphorylation | LNPISSVS------- CCCCCCCC------- | 36.13 | 26503892 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SMAD5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMAD5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-462; SER-463 ANDSER-465, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463 AND SER-465, ANDMASS SPECTROMETRY. |